This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth to Aid Eligible Medicaid Members in Kentucky
by Zacks Equity Research
UnitedHealth (UNH) and Commonwealth of Kentucky intends to improve health outcomes of Medicaid members in Kentucky, where it already has a strong presence.
The Zacks Analyst Blog Highlights: Alibaba, UnitedHealth, Merck, PetroChina and 3M
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alibaba, UnitedHealth, Merck, PetroChina and 3M
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $305.35 in the latest trading session, marking a -0.31% move from the prior day.
Top Stock Reports for Alibaba, UnitedHealth & Merck
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group (BABA), UnitedHealth (UNH) and Merck (MRK).
Molina Healthcare's New Deal to Boost Its Medicaid Business
by Zacks Equity Research
Molina Healthcare's (MOH) new agreement intends to efficiently serve its Medicaid members, which, in turn, will likely boost its market presence.
4 Health Insurance Companies in the Spotlight Right Now
by Zacks Equity Research
Based on a few positives, we narrowed down to four health insurers that deserve to be in your focus despite the COVID-19 crisis.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $303.97 in the latest trading session, marking a +0.07% move from the prior day.
Cigna's (CI) Earnings View Reaffirmation Reflects Solid Business Profile
by Sapna Bagaria
Cigna's (CI) retention of current-year guidance underlines its ability to tide over the present bleak business and economic landscape created by COVID-19.
5 Digital Health Stocks to Soar Amid Coronavirus Crisis
by Sreoshi Bera
The coronavirus pandemic has helped digital health surge like never before. With virtual visits increasing on a daily basis, we have five stocks that are set to gain.
Stocks Continue to Recover With Big Gains Across the Board
by David Borun
Despite some jitters about deteriorating US/China relations, equity indices stage another strong rally.
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $289.94, moving +1.06% from the previous trading session.
Humana, Healthmap Tie Up for Better Care to CKD Patients
by Zacks Equity Research
Humana (HUM) collaborates with Healthmap to offer better services to CKD patients in Florida.
Why Should You Retain Molina Healthcare in Your Portfolio?
by Zacks Equity Research
Riding high on its growing revenues and financial strength, Molina Healthcare (MOH) has potential to reap benefits to its investors.
UnitedHealth, Microsoft's New Mobile App to Help Trace Coronavirus
by Zacks Equity Research
UnitedHealth (UNH) and Microsoft will jointly launch a mobile application that will create a safe work ambience for employees returning to work by screening them for COVID-19 symptoms.
Microsoft (MSFT), UnitedHealth Partner on Return-to-Work App
by Zacks Equity Research
Microsoft (MSFT) ties up with UnitedHealth Group (UNH) to launch ProtectWell Protocol and App to aid employers in bringing employees back to workplace in a secure setting.
Humana (HUM) Rallies 59.3% in a Year: Further Upside Left?
by Zacks Equity Research
Humana's (HUM) solid Medicare business and inorganic growth story will likely boost its revenues, which in turn, might bump up its share price.
The Zacks Analyst Blog Highlights: UnitedHealth, AT&T, Netflix, Procter & Gamble and BlackRock
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, AT&T, Netflix, Procter & Gamble and BlackRock
UnitedHealthcare Ties Up to Improve Eye Health of Members
by Zacks Equity Research
UnitedHealth Group's (UNH) UnitedHealthcare business collaborates with GlassesUSA.com for providing improved eye care to its eligible members.
Top Research Reports for UnitedHealth, AT&T & Netflix
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group (UNH), AT&T (T) and Netflix (NFLX).
Medical Info Systems Outlook Bright Amid Coronavirus Crisis
by Urmimala Biswas
Despite the coronavirus-led worldwide sales disruption, Medical Info Systems is one of the few sectors witnessing industry-wide growth.
Magellan (MGLN) Q1 Earnings Top on Lower Medical Utilization
by Zacks Equity Research
Magellan Health's (MGLN) Q1 earnings benefit from higher profit owing to lower utilization of elective procedures.
Ensign Group's (ENSG) Q1 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) first-quarter 2020 results reflect strong revenues courtesy of robust segmental performance, partly offset by high costs.
Tenet Healthcare (THC) Q1 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) Q1 results reflect a strong operating performance and an income tax benefit, partly offset by the coronavirus outbreak.
Humana's (HUM) Earnings Beat Estimates in Q1, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) first-quarter results reflect better revenues and growth in Medicare Advantage business.
Community Health (CYH) Q1 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Community Health's (CYH) Q1 results hurt by softer revenues due to decline in admissions.